Tiziana Life Sciences

TLSANasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$115.119 M

$0.90 -0.11%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

120,507,401

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#299Coya TherapeuticsCOYA$116.1M
#300GeneluxGNLX$115.8M
#301Tiziana Life SciencesTLSA$115.1M
#302Milestone PharmaceuticalsMIST$114.3M
#303Cumberland PharmaceuticalsCPIX$113.7M

Insiders buying

All insider buying →

4 open-market purchases by officers and directors of Tiziana Life Sciences, worth $1.04M. Grants and option exercises are excluded.

Gabriele M. Cerrone$41.9K
42,357 shares at $0.99 on 21 Jul 2026 · filed 7 Aug 2026
Gabriele M. Cerrone$16.6K
15,000 shares at $1.11 on 12 Jun 2026 · filed 7 Aug 2026
Ivor ElrifiChief Executive Officer$318.9K
321,423 shares at $0.99 on 4 Aug 2026 · filed 6 Aug 2026
Ivor ElrifiChief Executive Officer$667.0K
667,000 shares at $1.00 on 3 Aug 2026 · filed 5 Aug 2026

What if Tiziana Life Sciences were worth as much as…

Open the what-if tool →

Gold $30.3T

$237,892.98

Per share 262,981× higher

Bitcoin $1.72T

$13,514.19

Per share 14,939× higher

Nvidia $5.48T

$43,060.63

Per share 47,602× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Tiziana Life Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.